Development and Validation of a Method for the Determination of Moexipril in Pharmaceutical Preparations

Key Points

• The newly developed method confirms moexipril detection with high precision, which is crucial for pharmaceutical applications.
• Sample recovery rates averaged 98% across various formulations, demonstrating consistent performance in quantification.
• Assessment using quantitative analysis ensures the method meets industry standards for validation in pharmaceuticals.
• This method highlights the necessity for robust techniques in drug quality control and may enhance regulatory compliance.

Abstract